To promote the adoption of teenagers from foster care, the Administration for Children and Families (ACF), AdoptUSKids and the Ad Council are unveiling a new series of multimedia public service advertisements (PSAs). Today, more than 33,000 teenagers await adoption from the U.S. foster care system. Nearly 50 percent (14,000) are between the ages of 14 and 16.
These new PSAs are part of the Adoption from Foster Care campaign launched in 2004. Since the launch of the campaign more than 15,000 children have been placed with a permanent family.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58394-ad-council-adoption-psas-raise-awareness-of-teenagers-in-us-foster-care
In recognition of International Women’s Day, Avon Foundation for Women Ambassador Salma Hayek Pinault and Avon Products, Inc. CEO Sheri McCoy announced that four global organizations and one government campaign have received 2nd Avon Communications Awards: Speaking Out About Violence Against Women for their outstanding work to bring attention to the need to end violence against women. The awards, presented at the United Nations Headquarters during the 57th session of the Commission on the Status of Women, are part of the Avon Speak Out Against Domestic Violence program, which has donated nearly $50 million globally to end violence against women since its launch in 2004.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60518-salma-hayek-pinault-presents-2nd-avon-global-communications-awards
InSightec Ltd, the leader in magnetic resonance imaging (MRI)-guided Focused Ultrasound therapy, announced that the U.S. Food and Drug Administration (FDA) has approved ExAblate® MRI-guided focused ultrasound as a therapy to treat pain from bone metastases in patients who do not respond or cannot undergo radiation treatment for their pain. This is the second FDA approval for ExAblate, which has been used widely since it was approved in 2004 as a non-invasive, outpatient, therapy for uterine fibroids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56632-insightec-fda-approves-exablate
